We are driven by a singular mission: Apply known biology to create novel, easy to administer therapies that materially benefit patients with autoimmune diseases. Our team is led by industry experts with a track record of stakeholder value creation.

Profile

Social Media

Candid Therapeutics Company Twitter Account

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Ken Song

Chief Financial Officer

Arvind Kush

Chief Medical Officer

Tim Lu

Chief Technical Officer

Bernie Huyghe

Vice President

Kathryn Shah

VP - General Counsel

Jeff Woodley

VP - Operations

David Luo

VP - Regulatory Affairs

Rozalyn Littler

Browse more venture capital transactions:

Prev: 9/9/2024: Cercli venture capital transaction
Next: 9/9/2024: Pin AI venture capital transaction

Share this article

News on VC Transactions

We report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary